PBAC Public Summary Document - March 2013
Page last updated: 6 April 2018
Public Summary Documents relating to the March 2013 PBAC meeting.
- ADALIMUMAB, injection, 40 mg in 0.8 mL pre-filled syringe, 40 mg in 0.8 mL pre-filled pen, Humira®
- ALGLUCOSIDASE ALFA-RCH, powder for I.V. infusion, 50 mg, Myozyme®
- APIXABAN, tablet, 2.5 mg and 5 mg, Eliquis®
- COBICISTAT+ELVITEGRAVIR+EMTRICITABINE+TENOFOVIR, tablet, cobicistat 150 mg, elvitegravir 150 mg, emtricitabine 200 mg, tenofovir 300 mg, Stribild®
- COBICISTAT, tablet (film coated), 150mg, Tybost®
- CORIFOLLITROPIN ALFA, solution for injection, 150 microgram in 0.5 mL pre-filled syringe, Elonva ®
- DABIGATRAN ETEXILATE, capsules, 110 mg and 150 mg (as mesilate), Pradaxa®
- DABRAFENIB, capsule, 50 mg and 75 mg, Tafinlar®
- ECULIZUMAB, concentrated solution for I.V. infusion, 300 mg in 30 mL, Soliris®
- ELVITEGRAVIR, tablet (film coated), 85 mg and 150 mg, Vitekta®
- ERIBULIN MESILATE, solution for injection, 1mg in 2mL Halaven®
- EVEROLIMUS, tablet, 5 mg and 10 mg, Afinitor®
- FENTANYL CITRATE, nasal spray, 6 pack of single-dose nasal spray bottles 50 microgram, 100 microgram, 200 microgram, Instanyl®
- FERRIC CARBOXYMALTOSE, solution for injection, 100 mg in 2 ml and 500 mg in10ml, Ferinject®
- INFLIXIMAB, powder for IV infusion, 100mg, Remicade®
- INSULIN DEGLUDEC, injection solution, 100 IU/mL and 200 IU/mL, Tresiba Flextouch® and Tresiba Penfill®
- LENALIDOMIDE, capsules, 5 mg and 10 mg, Revlimid®
- LINAGLIPTIN with METFORMIN HYDROCHLORIDE, tablets, 2.5 mg/500 mg, 2.5 mg/850 mg and 2.5 mg/1000 mg, Trajentamet®
- LIRAGLUTIDE, solution for injection, 6mg/mL, Victoza®
- MIFEPRISTONE, tablet 200 mg, Mifepristone Linepharma, and Misoprostol, tablet 200 microgram, GyMiso®
- PANITUMUMAB, concentrate solution for infusion, 100 mg in 5mL & 400 mg in 20 mL, Vectibix®
- RANIBIZUMAB, solution for intravitreal injection, 2.3 mg in 0.23 mL, Lucentis®
- RISEDRONATE SODIUM, tablets, 5mg Actonel®, tablet 35mg (enteric coated) Actonel EC®, tablet 150mg Actonel Once-a-Month®
- RIVAROXABAN (PE), tablets, 15 mg and 20 mg, Xarelto®
- RIVAROXABAN (SPAF), tablets, 15 mg and 20 mg, Xarelto®
- SAXAGLIPTIN with METFORMIN, tablet, 2.5 mg/500 mg, 2.5 mg/850 mg and 2.5 mg/1000 mg, Kombiglyze®
- TOBRAMYCIN, powder for inhalation, capsules 28 mg, Tobi® Podhaler®
- VEMURAFENIB, tablet, 240 mg, Zelboraf®
